Article Text

Download PDFPDF
Use of short-acting beta agonists in the treatment of asthma across five European countries
  1. Pavlou Panagiotis1,
  2. Jo Congleton2
  1. 1Clinical Pharmacology, St George's University of London, London, UK
  2. 2Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
  1. Correspondence to Dr Jo Congleton, Brighton and Sussex University Hospitals NHS Trust, Brighton, BN2 5BE, UK; jo.congleton{at}


Commentary on: Janson C, Menzies-Gow A, Nan C, et al. SABINA: an overview of short-acting β2-agonist use in asthma in European countries. Adv Ther. 2020;37:1124–35.

  • asthma
  • therapeutics

Statistics from


  • Series co-ordinator Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George’s, University of London, UK

  • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.